March 19, 2014
05:38 EDT NUS Nu Skin China language in-line with expectations, says Deutsche Bank
Deutsche Bank views Nu Skin's language last night in its regulatory filing relating to the inquiries from government regulators in China as in-line with expectations. The firm believes shares are discounting no sales or EBIT growth from current levels and it continues to see significant upside over the next 12 months. Deutsche keeps a Buy rating on Nu Skin with a $110 price target.
Here was their previous recommendation, right before the investigation was announced (couldn't have been more wrong):
"Nu Skin is trading down sharply today on an article in the Chinese newspaper People's Daily, questioning the legitimacy of its business practices in China, the latest in a series of attacks on the company, particularly as it relates to its Chinese business. While the translation of the article is admittedly choppy, it appears to focus on issues that we view as largely inconsequential to the company's ultimate success in the Chinese market, noting that Nu Skin has responded to the article by saying it contains inaccuracies and exaggerations that are not representative of its business in China," said Schmitz
"Further, many sources on the ground in Asia have suggested that this news source has a history of attacking various other companies, and we note that this is the third negative article on Nu Skin in a row (from various sources) that has been published the week of options expiry. We view today's pullback as a buying opportunity, noting that we are meeting with management tomorrow in Hong Kong and will follow up with details post our meetings," he added.
Deutsche Bank has a Buy rating on Nu Skin with a price target of $150.00